Subacute Cutaneous Lupus Erythematosus (SCLE) is a rare and chronic skin disorder that affects approximately 1 in 250,000 people. It is a type of autoimmune disorder, meaning that the body’s immune system mistakenly attacks healthy tissue. SCLE is a type of lupus, a group of diseases that can affect any part of the body, including the skin, joints, and organs. While the exact cause of SCLE is unknown, it is believed to be triggered by certain environmental factors, such as exposure to sunlight, certain medications, and infections. SCLE is characterized by a rash that usually appears on the upper body, neck, and arms. The rash is typically red, scaly, and may be accompanied by itching.
Subacute Cutaneous Lupus Erythematosus (SCLE) is a chronic, autoimmune skin disorder that is characterized by a rash on the upper body, neck, and arms. The rash typically appears as red, scaly patches and may be accompanied by itching. SCLE is considered to be a type of lupus, a group of diseases that can affect any part of the body, including the skin, joints, and organs. SCLE is believed to be triggered by certain environmental factors, such as exposure to sunlight, certain medications, and infections.
The most common symptom of SCLE is a rash on the upper body, neck, and arms. The rash typically appears as red, scaly patches and may be accompanied by itching. Other symptoms of SCLE may include: • Fatigue • Joint pain • Muscle aches • Fever • Hair loss • Mouth sores • Photosensitivity
SCLE can be difficult to diagnose because its symptoms can be similar to other skin conditions. To diagnose SCLE, doctors will typically take a medical history and conduct a physical exam. The doctor may also order blood tests to look for antibodies associated with lupus. In some cases, a skin biopsy may be necessary to confirm the diagnosis.
The primary goal of treatment for SCLE is to reduce inflammation and relieve symptoms. Treatment may include topical or oral medications, such as corticosteroids, antimalarials, and immunosuppressants. In some cases, phototherapy may also be recommended.
The exact cause of SCLE is unknown, so it is not possible to prevent the condition. However, there are some steps that can be taken to reduce the risk of flare-ups. These include avoiding direct sunlight, wearing protective clothing, and using sunscreen with an SPF of at least 30. Additionally, people with SCLE should avoid certain medications and infections that may trigger a flare-up.
Living with SCLE can be difficult, but there are ways to manage the condition and reduce the risk of flare-ups. It is important to follow the treatment plan prescribed by your doctor and to take steps to protect your skin from the sun. Additionally, it is important to take care of your mental health by engaging in activities that you enjoy and seeking support from family and friends.
Subacute Cutaneous Lupus Erythematosus (SCLE) is a rare and chronic skin disorder that affects approximately 1 in 250,000 people. It is a type of autoimmune disorder, meaning that the body’s immune system mistakenly attacks healthy tissue. The exact cause of SCLE is unknown, but it is believed to be triggered by certain environmental factors. SCLE is characterized by a rash that usually appears on the upper body, neck, and arms. Treatment for SCLE may include medications, phototherapy, and lifestyle changes. While there is no known cure for SCLE, it is possible to manage the condition and reduce the risk of flare-ups.
1.
The way that miR-377 inhibits cells that cause prostate cancer.
2.
Five new papers highlight cancer inequities, challenges and opportunities in South Asia
3.
The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.
4.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
5.
Survivors of childhood brain cancer are more likely to be held back in school
1.
Precision Era in Pediatric Oncology, from Genomic Breakthroughs to Lifelong Learning
2.
Fibroma: Understanding the Causes, Symptoms, and Treatment Options
3.
Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine
4.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
5.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation